{"component": "definition", "props": {"groups": [{"samples": [{"hash": "1uvzmh5v2qc", "uri": "/contracts/1uvzmh5v2qc#development-programs", "label": "Collaboration and Exclusive License Agreement", "score": 31.340862423, "published": true}, {"hash": "etsp1WeQQGh", "uri": "/contracts/etsp1WeQQGh#development-programs", "label": "Collaboration and Exclusive License Agreement (Anaptysbio Inc)", "score": 27.3545516769, "published": true}, {"hash": "gKwAwCNzYk9", "uri": "/contracts/gKwAwCNzYk9#development-programs", "label": "Collaboration and Exclusive License Agreement (Anaptysbio Inc)", "score": 27.1245722108, "published": true}], "snippet_links": [{"key": "pd-1-development-program", "type": "definition", "offset": [25, 49]}, {"key": "lag-3-development-program", "type": "definition", "offset": [81, 106]}], "snippet": "means, collectively, the PD-1 Development Program, \u2587\u2587\u2587-3 Development Program and LAG-3 Development Program, and \u201cDevelopment Program\u201d shall mean any of such programs.", "size": 6, "hash": "f447822710022973bc5e04b2767f79b9", "id": 1}, {"samples": [{"hash": "5xEZZRz7Z5p", "uri": "/contracts/5xEZZRz7Z5p#development-programs", "label": "License Agreement (Lineage Cell Therapeutics, Inc.)", "score": 35.6009582478, "published": true}, {"hash": "6xLHdcP3zdB", "uri": "/contracts/6xLHdcP3zdB#development-programs", "label": "License Agreement (Biotime Inc)", "score": 28.6030116359, "published": true}, {"hash": "fm6v9DaoiEH", "uri": "https://mayafiles.tase.co.il/rpdf/1610001-1611000/P1610024-00.pdf", "label": "mayafiles.tase.co.il", "score": 19.2125976175, "published": false}], "snippet_links": [{"key": "research-and-development", "type": "definition", "offset": [14, 38]}, {"key": "for-the-company", "type": "definition", "offset": [58, 73]}, {"key": "the-product", "type": "clause", "offset": [123, 134]}, {"key": "second-amendment-date", "type": "definition", "offset": [297, 318]}, {"key": "new-product-development-agreement", "type": "definition", "offset": [336, 369]}, {"key": "the-development-program", "type": "clause", "offset": [371, 394]}, {"key": "the-period", "type": "clause", "offset": [399, 409]}, {"key": "commencing-from", "type": "clause", "offset": [410, 425]}, {"key": "appendix-a", "type": "definition", "offset": [455, 465]}, {"key": "from-time-to-time", "type": "clause", "offset": [562, 579]}, {"key": "pursuant-to-the-provisions", "type": "clause", "offset": [580, 606]}], "snippet": "means (i) the research and development carried out by HMO for the Company from January 1, 2009 to June 14 2016 pursuant to the Product Development Agreement, and (ii) the research and development that has been carried out since June 15, 2016 and that will continue to be carried out following the Second Amendment Date, pursuant to the New Product Development Agreement. The Development Program for the period commencing from June 15, 2016 is attached as Appendix A to the New Product Development Agreement (the \u201cCurrent Development Program\u201d), as may be amended from time to time pursuant to the provisions thereof.", "size": 6, "hash": "25f388209ac3450f9fa1e769435143fe", "id": 2}, {"samples": [{"hash": "hrmm9qXvkhf", "uri": "/contracts/hrmm9qXvkhf#development-programs", "label": "Commercial Supply Agreement (Horizon Therapeutics Public LTD Co)", "score": 30.1485284052, "published": true}, {"hash": "kRNritUN5Uj", "uri": "/contracts/kRNritUN5Uj#development-programs", "label": "Commercial Supply Agreement (Horizon Pharma PLC)", "score": 26.3976728268, "published": true}, {"hash": "hQyNW2JqkCT", "uri": "/contracts/hQyNW2JqkCT#development-programs", "label": "Commercial Supply Agreement (Horizon Pharma PLC)", "score": 25.6009582478, "published": true}], "snippet_links": [{"key": "work-carried", "type": "clause", "offset": [31, 43]}], "snippet": "means research and development work carried out by BTG for Savient.", "size": 5, "hash": "b6285ea2e1c385f2d681ea6f90fd987e", "id": 3}, {"samples": [{"hash": "dA1aku2CxWW", "uri": "/contracts/dA1aku2CxWW#development-programs", "label": "Memorandum of Understanding", "score": 33.6301331531, "published": true}, {"hash": "7pm36A0iXcB", "uri": "/contracts/7pm36A0iXcB#development-programs", "label": "Memorandum of Understanding", "score": 33.6301331531, "published": true}, {"hash": "7Lc2PYT5NvX", "uri": "/contracts/7Lc2PYT5NvX#development-programs", "label": "Memorandum of Understanding", "score": 27.6543463381, "published": true}], "snippet_links": [{"key": "faculty-members", "type": "clause", "offset": [26, 41]}, {"key": "academic-requirement", "type": "definition", "offset": [106, 126]}, {"key": "the-national", "type": "clause", "offset": [139, 151]}, {"key": "if-available", "type": "definition", "offset": [196, 208]}, {"key": "student-members", "type": "definition", "offset": [227, 242]}, {"key": "the-training", "type": "clause", "offset": [316, 328]}, {"key": "to-the-student", "type": "clause", "offset": [329, 343]}, {"key": "the-first-party", "type": "definition", "offset": [355, 370]}, {"key": "the-relevant", "type": "clause", "offset": [406, 418]}, {"key": "educational-institutions", "type": "clause", "offset": [477, 501]}, {"key": "online-activities", "type": "clause", "offset": [576, 593]}, {"key": "the-second-party", "type": "clause", "offset": [607, 623]}, {"key": "financial-charges", "type": "clause", "offset": [646, 663]}, {"key": "the-institutes", "type": "definition", "offset": [673, 687]}, {"key": "participation-fee", "type": "clause", "offset": [778, 795]}, {"key": "registered-student", "type": "clause", "offset": [824, 842]}, {"key": "faculty-coordinators", "type": "clause", "offset": [855, 875]}, {"key": "accommodation-expenses", "type": "clause", "offset": [902, 924]}], "snippet": "Second Party to train the Faculty members of First Party for imparting training as per the industrial and academic requirement considering the National Occupational Standards in concerned sector, if available. Placement Aid to Student Members: Second Party will actively engage to help and assist in the delivery of the training to the student members of the First Party into internships/job placements in the relevant sector. Institutional Participation: The First Party i.e. educational institutions shall ensure participation of Faculty Coordinator and Students in all the Online Activities conducted by the Second Party i.e, RESI without any financial charges. However the institutes are free to decide on participation or otherwise in offline activities of RESI wherein no participation Fee shall be charged by RESI to registered student members and faculty coordinators, however TA/DA/Conveyance/Accommodation expenses are to be borne by the First Party only etc.", "size": 4, "hash": "6a5fb047dfd35381cb989bd6fb74b6e8", "id": 4}, {"samples": [{"hash": "6KIaBz4roMV", "uri": "/contracts/6KIaBz4roMV#development-programs", "label": "License and Collaboration Agreement (Immunocore LTD)", "score": 32.0390143737, "published": true}, {"hash": "aRVJiIiSf6F", "uri": "/contracts/aRVJiIiSf6F#development-programs", "label": "License and Collaboration Agreement (Immunocore LTD)", "score": 31.9733059548, "published": true}], "snippet_links": [{"key": "the-pre", "type": "clause", "offset": [6, 13]}, {"key": "global-development-program", "type": "clause", "offset": [46, 72]}], "snippet": "means the Pre-POC Development Program and the Global Development Program.", "size": 2, "hash": "f4f5ba1595c271ad1a4a79f68cde1328", "id": 5}, {"samples": [{"hash": "ke5S7xGdx4y", "uri": "/contracts/ke5S7xGdx4y#development-programs", "label": "Development Collaboration and License Agreement (Alteon Inc /De)", "score": 18.0, "published": true}], "snippet_links": [], "snippet": "shall have the meaning set forth in Section 3.4(a).", "size": 2, "hash": "93c46b93eaebfeba83548e81fc0a2401", "id": 6}, {"samples": [{"hash": "N4CaYl6y6R", "uri": "/contracts/N4CaYl6y6R#development-programs", "label": "Transgenic Animal Non Exclusive License and Sponsored Research Agreement (Intellect Neurosciences, Inc.)", "score": 17.0, "published": true}], "snippet_links": [{"key": "field-of", "type": "definition", "offset": [82, 90]}, {"key": "central-nervous-system", "type": "definition", "offset": [121, 143]}, {"key": "by-licensee", "type": "clause", "offset": [188, 199]}], "snippet": "means pharmaceutical, biotechnological and diagnostic development programs in the field of Alzheimer\u2019s Disease and other central nervous system and neurodegenerative diseases as performed by LICENSEE or its Affiliates.", "size": 1, "hash": "5f70ac9a2c5282b508d418c40bfa5857", "id": 7}, {"samples": [{"hash": "kbySkr20bGr", "uri": "/contracts/kbySkr20bGr#development-programs", "label": "Collaborative Development Agreement", "score": 30.340862423, "published": true}], "snippet_links": [], "snippet": "shall have the meaning set forth in Section 3.1(a). (n)\u201cDraft\u201d shall have the meaning set forth in Section 11.2(f). (o)\u201cDRAM Field\u201d shall mean [***].", "size": 1, "hash": "c4d6f26a86afbe4d74475cc625813a28", "id": 8}, {"samples": [{"hash": "9Q8swwu9F8r", "uri": "/contracts/9Q8swwu9F8r#development-programs", "label": "Joint Venture Agreement (Ballard Power Systems Inc.)", "score": 29.9062286105, "published": true}], "snippet_links": [{"key": "rd-agreement", "type": "clause", "offset": [33, 46]}], "snippet": "has the meaning set forth in the R&D Agreement;", "size": 1, "hash": "7be2aea3fe1f57b010adee3096bef206", "id": 9}, {"samples": [{"hash": "yZP6cLUGYl", "uri": "http://pdf.secdatabase.com/336/0000950170-24-094004.pdf", "label": "pdf.secdatabase.com", "score": 19.8590266614, "published": false}], "snippet_links": [{"key": "research-and-development", "type": "definition", "offset": [14, 38]}, {"key": "for-the-company", "type": "definition", "offset": [58, 73]}, {"key": "product-development-agreement", "type": "definition", "offset": [127, 156]}], "snippet": "means (i) the research and development carried out by HMO for the Company from January 1, 2009 to June 14 2016 pursuant to the Product Development Agreement, and", "size": 1, "hash": "72f2739fadef62512b3734ce44babbae", "id": 10}], "next_curs": "CmESW2oVc35sYXdpbnNpZGVyY29udHJhY3Rzcj0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIdZGV2ZWxvcG1lbnQtcHJvZ3JhbXMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"title": "Development Programs", "snippet": "means, collectively, the PD-1 Development Program, \u2587\u2587\u2587-3 Development Program and LAG-3 Development Program, and \u201cDevelopment Program\u201d shall mean any of such programs.", "size": 34, "id": "development-programs", "examples": ["Article applies to all Early Childhood Education/Child <strong>Development Programs</strong>.", "The CDC shall prepare recommendations concerning the Career <strong>Development Programs</strong> and Career Development Assistance to be implemented at the College/University, and from time to time, as needed, will make recommendations for improvements.", "The Parties are entering into this Contract for the Contractor to provide Training, Assessments &amp; <strong>Development Programs</strong> to Purchasing Entities.", "Participating contractors, subcontractors, and other participants must comply with regulations issued under these Acts and with other federal laws and regulations pertaining to labor standards and HUD Handbook 1344.1 (Federal Labor Standards Compliance in Housing and Community <strong>Development Programs</strong>), as applicable.", "During these monthly meetings, the Parties will review the activities undertaken in connection with any ongoing <strong>Development Programs</strong>, report on the progress towards achieving any established goals and objectives and/or any perceived challenges or impediments to achieving such objectives, discuss the status of the scope of work and any associated milestones and timelines and make adjustments to the scope of work, milestones and/or timelines as deemed necessary or beneficial.", "As of the date of receipt of that notice, each Party may decide to discontinue disclosing Confidential Information relating to its Independent Technology to the other Party for the pending <strong>Development Programs</strong>; however, except in the case of a termination the Development Program in question or the entire Agreement, the Parties agree to work together diligently to bring each pending Development Program to a logical and orderly close.", "Among other things, the Parties shall meet promptly thereafter in order to (a) prioritize work during the remaining term of each Development Project, and (b) agree upon a reasonable time frame for the Parties to diligently complete such <strong>Development Programs</strong> on which the Parties are close to completion.", "If a particular Development Program is terminated without the termination of the entire Agreement, this Agreement will be terminated only with respect to such Development Program and will remain in effect with respect to the then outstanding <strong>Development Programs</strong> in accordance with their terms and or any other <strong>Development Programs</strong> the Parties decide to pursue under this Agreement.", "Each party shall use commercially reasonable efforts to timely conduct its obligations under the <strong>Development Programs</strong> in accordance with the Development Plan.", "In general, the functions of the Steering Committee would be to provide strategic direction to the Program Leaders and make informed decisions regarding the direction, management and implementation of the Development Program(s)."], "related": [["development-program", "Development Program", "Development Program"], ["development-plans", "Development Plans", "Development Plans"], ["development-activities", "Development Activities", "Development Activities"], ["research-program", "Research Program", "Research Program"], ["development-plan", "Development Plan", "Development Plan"]], "related_snippets": [], "updated": "2025-07-07T00:16:46+00:00"}, "json": true, "cursor": ""}}